Facts & figures

      Facts and figures on our smoke-free future

      See the evidence of our transition toward a smoke-free future: read these key facts and figures.

       

      Philip Morris International’s value creation model describes what we do and how we allocate our resources to deliver long-term value for both our company and our stakeholders. In 2016, we announced our vision of a smoke-free future and our ambition to accelerate the end of smoking. To achieve this, we are working to replace cigarettes with less harmful tobacco and nicotine products for the benefit of adults who would otherwise continue to smoke. 

       

      These facts and figures were most recently updated in April 2023. You can read our latest Integrated Report to learn more about some of these key facts and figures, as well as other performance metrics.

      * Data does not include employees of Swedish Match or Vectura Fertin Pharma.

      ** IP5 jurisdictions are Europe (patents granted by the European Patent Office), China, South Korea, Japan, and the U.S.

      Timeline

      See the facts for yourself

      We've created a timeline of events showing some of our biggest milestones in our journey to build a smoke-free future. Check out this timeline and more in our media library.

      Browse the Media Library
      Related articles

      PMIScience.com is operated by Philip Morris International for the purpose of publishing and disseminating scientific information about Philip Morris International’s efforts to develop and assess products that have the potential to reduce individual risk and population harm associated with tobacco use. This site is for use by scientists, the public health and regulatory communities, and other stakeholders with an interest in tobacco policy. The purpose of this site is not for advertising or marketing. It is not intended for use by consumers.

      Reduced Risk Products ("RRPs”) is the term we use to refer to products that present, are likely to present, or have the potential to present less risk of harm to smokers who switch to these products versus continuing smoking. PMI has a range of RRPs in various stages of development, scientific assessment and commercialization. Our RRPs are smoke-free products that produce an aerosol that contains far lower quantities of harmful and potentially harmful constituents than found in cigarette smoke.